Conclusion:
Acquired EV is a recent and rare entity, occurring in conditions with compromised cell-mediated immunity such as renal transplantation. The number of renal-transplant recipients has significantly increased in recent years which may lead to an increase in the prevalence of acquired EV. Transplant recipients are at high risk of developing non-melanoma skin cancers.16 It is important to recognize and accurately diagnose acquired EV because its impact on the cancer risk and its consequences on patient monitoring is still unknown. Cohort studies are required with long-term follow-up and continued evaluation to assess the relative risk for secondary skin cancers. The importance of regular sunscreen application must be stressed. Physicians should play a key role for the long-term dermatologic surveillance of this high-risk population.